Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2016 08:05 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Announces NARCAN® Nasal Spray Approved by Health Canada

SANTA MONICA, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
August 18, 2016 08:45 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals to Present at the Rodman & Renshaw Conference on September 13 in New York City

SANTA MONICA, Calif., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
June 09, 2016 08:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2016 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
May 12, 2016 08:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Announces Appointments of Gabrielle A. Silver, M.D., and Ann MacDougall to Board of Directors

SANTA MONICA, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
May 06, 2016 08:30 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.’s Partner, Adapt Pharma Limited, Submits New Drug Submission for Naloxone Nasal Spray to Health Canada

SANTA MONICA, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance...
March 16, 2016 08:30 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., Reports Fiscal Second Quarter 2016 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
March 07, 2016 16:05 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., Announces Ticker Symbol Change to “OPNT”

SANTA MONICA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for...
March 07, 2016 08:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., Receives $2.5 Million Milestone Payment Following Adapt Pharma Limited’s First Commercial Sale of NARCAN® (Naloxone Hydrochloride) Nasal Spray in the U.S.

SANTA MONICA, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for...
February 17, 2016 08:45 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., Convenes Medical Advisory Board to Support Development of Pharmacological Treatments for Substance Use, Addictive and Eating Disorders

SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
February 17, 2016 08:30 ET | Source: Opiant Pharmaceuticals, Inc.

Lightlake Therapeutics Inc. Announces Name Change to Opiant Pharmaceuticals, Inc.

SANTA MONICA, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...